Peter David Suzdak Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter David Suzdak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter David Suzdak. Peter David Suzdak is an Chief Executive Officer in REXAHN PHARMACEUTICALS, INC. ($RNN) and a Director in AEOLUS PHARMACEUTICALS, INC. ($INCR.OB).
Address: P.O. BOX 14287, 79 TW ALEXANDER DR. 4401 RESEARCH COMMONS, SUITE 200 RTP 27709-4287 NC
Companies in which Peter David Suzdak is an Insider
AEOLUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter David Suzdak: Director
Holdings: 0 shares
Latest Transaction: Sep 23 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocuphire Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter David Suzdak: Chief Executive Officer
Holdings: 22,250 shares
Current Value: $4,005
Latest Transaction: Mar 02 2018
$RNN Market Capitalization: $41.78M
$RNN Previous Close: $0.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Peter David Suzdak
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
| Mar 02 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Buy | M | 0.00 | 6,250 | 0 | 22,250 | 16 K to 22.3 K (+39.06 %) |
| Jan 30 2018 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 2.29 | 112,271 | 257,101 | 112,271 | |
| Aug 16 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Grant | A | 1.99 | 10,000 | 19,872 | 16,000 | 6 K to 16 K (+166.67 %) |
| Jan 24 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
| Jan 24 2017 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.18 | 1,175,000 | 216,200 | 1,175,000 | |
| Mar 21 2016 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Grant | A | 0.32 | 60,000 | 19,386 | 60,000 | 0 to 60 K |